Problems › Where Should We Invest Next?
Capital allocation goes wrong when the loudest line gets funded rather than the one with the best return on the next dollar.
Capital allocation goes wrong when the loudest line gets funded rather than the one with the best return on the next dollar.
Most businesses allocate by history and by advocacy: the lines that got money last year get it again, and the person who argues best gets the increment. Neither has anything to do with where the next dollar earns most.
The analysis that helps ranks each line on two things — what it returns on incremental investment, and how durable that return is. A line that returns well but decays in eighteen months is a different proposition from one that returns modestly for a decade, and treating them as comparable is how businesses end up funding decline.
The output should be a sequence with a stopping rule, not a budget split. Which one first, what it funds next, and the observation that would say the sequence is wrong.
These three together are the signature. One on its own usually points somewhere else.
✓ Budgets are set by last year plus a percentage
✓ Nobody can rank the lines by return on incremental investment
✓ Investment decisions are defended by strategic importance rather than by arithmetic
The move that usually makes it worse. Spreading capital evenly to keep the peace, which underfunds the one thing that would have compounded.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
The diagnosis changes with the shape of the business. Each of these works the same question through one industry's actual economics, with an excerpt from a real analysis run on a company of that type.
It routes to Growth Portfolio Framework (catalog id bcg-v2), one of 29 engagements. The output is a sequence with a stopping rule — which move first, what it funds next, and the observation that would say it is not working — rather than a list of things you could consider.
Read a complete report before deciding whether it is worth your time.
The figures an engine can cite for this question come from a completed run on Aldergate Partners, a sample profile (professional services, $88M revenue, 310 people), not a customer. Several industry variants currently republish the same excerpt — they are not different datasets.
Addressable proof excerpt — $85K diagnostic → $410K implementation, 25% of diagnostic-eligible opportunities diverted to T&M, $700K / 3.4× / NPV $2.4M, kill criteria as published.
Price the durability explicitly. A return that decays needs a stated half-life; once each option carries one, options with different horizons become comparable rather than a matter of taste.
Usually the strongest, because that is where a marginal dollar compounds. Fixing the weakest is worth doing when it is a constraint on the strongest, and not otherwise.
Then decide on reversibility. When two options return similarly, take the one you can stop, because the value of the information you buy exceeds the difference in the estimates.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.